top of page
ABOUT
TEAM
PORTFOLIO
NEWS
CONTACT
More
Use tab to navigate through the menu items.
NEWS
Compass Therapeutics Receives FDA Fast Track Designation for CTX-009 in Combination with Paclitaxel
04.25.24
Compass Therapeutics Announces First Patient Dosed in the Phase 1 Study of CTX-8371
04.16.24
Ankyra Therapeutics and Jenga Biosciences Announce Exclusive License Agreement for JEN-101
03.26.24
Ankyra Therapeutics Announces First Patient Dosed in Phase 1 Trial Evaluating ANK-101
03.05.24
Compass Therapeutics Announces Publication of Preclinical Data for CTX-8371
02.28.24
Adimab Provides Year-End Update on 2023 Partnership Activities
01.08.24
Page 1 of 17
bottom of page